v3.26.1
Commitments and Contingencies (Tables)
6 Months Ended
Jun. 30, 2026
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Lease Cost As of June 30, 2026, the Company had the following building and facility leases capitalized on the balance sheet:

 

Location (leases)

 

Purpose

 

Expiration

 

 

 

 

 

Americas

 

 

 

 

Vaughan, Canada

 

Canada sales office and distribution

 

August 2026

Fox River Grove, IL (2)

 

RestoreFlow allografts business

 

December 2026

North Brunswick, NJ

 

Artegraft biologic business

 

October 2029

Burlington, MA (2)

 

Corporate headquarters and US distribution

 

December 2030

Billerica, MA

 

US distribution

 

December 2032

Burlington, MA (4)

 

Corporate headquarters and manufacturing

 

December 2034

Mississauga, Canada

 

Canada sales office and distribution

 

March 2036

 

 

 

 

 

Europe, Middle East and Africa

 

 

 

 

Milan, Italy

 

Italy sales office and distribution

 

September 2027

Madrid, Spain

 

Spain sales office and distribution

 

June 2029

Hereford, England

 

United Kingdom sales office and distribution

 

October 2029

Maisons-Alfort, France

 

France sales office and distribution

 

February 2030

Glattbrugg, Switzerland

 

Switzerland sales office and distribution

 

February 2030

Dublin, Ireland

 

Ireland sales office and distribution

 

September 2030

Sulzbach, Germany

 

European headquarters and distribution

 

June 2031

 

 

 

 

 

Asia Pacific

 

 

 

 

Bangkok, Thailand

 

Thailand sales office and distribution

 

August 2026

Seoul, Korea

 

Korea sales office and distribution

 

April 2027

Tokyo, Japan

 

Japan sales office and distribution

 

July 2027

Shanghai, China

 

China sales office and distribution

 

October 2027

Singapore

 

Asia Pacific headquarters and distribution

 

June 2028

Docklands, Australia

 

Australia sales office and distribution

 

April 2030

Ballarat, Australia

 

Supply facility

 

December 2030

Additional information with respect to the Company’s leases is as follows:

 

 

Three months ended June 30,

 

 

Six months ended June 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

(in thousands)

 

 

(in thousands)

 

Lease cost

 

 

 

 

 

 

 

 

 

 

 

 

Operating lease cost

 

$

1,325

 

 

$

447

 

 

$

2,662

 

 

$

1,041

 

Short-term lease cost

 

 

20

 

 

 

20

 

 

 

50

 

 

 

46

 

Total lease cost

 

$

1,345

 

 

$

467

 

 

$

2,712

 

 

$

1,087

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining lease term - operating
   leases (in years)

 

 

 

 

 

 

 

 

6.5

 

 

 

6.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average discount rate - operating leases

 

 

 

 

 

 

 

 

6.48

%

 

 

6.62

%

Schedule of Minimum Noncancelable Operating Lease Rental Commitments with Initial or Remaining Terms

As of June 30, 2026, the minimum noncancelable operating lease rental commitments with initial or remaining terms of more than one year are as follows:

 

Remainder of 2026

 

$

2,441

 

Year ending December 31,

 

 

 

2027

 

 

4,284

 

2028

 

 

3,949

 

2029

 

 

3,792

 

2030

 

 

3,294

 

2031

 

 

2,564

 

Thereafter

 

 

6,025

 

Adjustment to net present value as of June 30, 2026

 

 

(5,186

)

 

 

 

 

Minimum noncancelable lease liability

 

$

21,163